Back to Search
RACHEL SMITH, PHARMD
PHARMD
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
NPI: 1922998863Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy SpecialistPrimary
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
RP444619(PA)
Research & Publications (20)
Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032.
PMID 17909906·Ann Surg Oncol·2007
8-other
Modern radiation treatment planning and delivery--from Röntgen to real time.
PMID 16580556·Hematol Oncol Clin North Am·2006
6-review
Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
PMID 15292384·J Natl Cancer Inst·2004
3-trial
Phase II trial of a doxorubicin/docetaxel doublet for locally advanced and metastatic breast cancer: results from national surgical adjuvant breast and bowel project trial BP-57.
PMID 15335453·Clin Breast Cancer·2004
3-trial
A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials.
PMID 14613021·Semin Oncol·2003
6-review
Chemoprevention of breast cancer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others.
PMID 14503912·Endocr Relat Cancer·2003
6-review
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
PMID 12663705·J Clin Oncol·2003
4-observational
Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience.
PMID 14651772·Clin Breast Cancer·2003
6-review
Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
PMID 12533263·Clin Breast Cancer·2002
3-trial
UFT/leucovorin vs 5-FU/leucovorin in colon cancer.
PMID 11098486·Oncology (Williston Park)·2000
3-trial
In vivo response to cross-linked polyethylene and polycarbonate-urethane particles.
PMID 19557792·J Biomed Mater Res A·2010
7-preclinical
Orexin/hypocretin is necessary for context-driven cocaine-seeking.
PMID 19591850·Neuropharmacology·2010
7-preclinical
In vitro macrophage response to polyethylene and polycarbonate-urethane particles.
PMID 19569215·J Biomed Mater Res A·2010
8-other
Comparison of motility, recovery, and methyl-thiazolyl-tetrazolium reduction assays for use in screening plant products for anthelmintic activity.
PMID 19629527·Parasitol Res·2009
7-preclinical
Keepers of the secret: desires to conceal a family member's HIV-positive status in Namibia, Africa.
PMID 19657828·Health Commun·2009
8-other
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
PMID 19628478·Hum Mol Genet·2009
7-preclinical
Intermedin is a new angiogenic growth factor.
PMID 19592612·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking.
PMID 19656173·Eur J Neurosci·2009
7-preclinical
Inactivating the activated: identifying functions of specific neural networks.
PMID 19636350·Nat Neurosci·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 120 5TH AVE STE 1048
PITTSBURGH, PA 15222 - Phone
- (412) 544-5227
Quick Facts
- NPI
- 1922998863
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile